ABSTRACT. Previously analyzed F 2 mice between KK/Ta and RR/Sgn strains were further investigated by defining appropriate permutation-derived threshold levels for significance and by searching pairwise gene interactions. In addition, a principal component analysis was conducted to extract a potential parameter that accounts for the joint occurrence of metabolic abnormalities. As a result, one significant interaction, containing novel QTL on chromosome 15, was identified for plasma total-cholesterol levels. For the principal component that potentially accounted for the joint occurrence of metabolic abnormalities, one significant QTL was identified on chromosome 12. This locus was not significant for any single trait. These complex genetic bases could not be disclosed as long as a separate trait was analyzed by traditional single QTL scans.
Plasma lipid concentrations are representative quantitative traits that are controlled by multiple genes together with non-genetic environmental effects. Alterations in plasma lipid levels are frequently associated with other metabolic disorders such as non-insulin-dependent diabetes mellitus (NIDDM) and obesity, and are recognized as major risk factors for cardiovascular disease as well [10] . Molecular mechanisms for genetic control of plasma lipid levels have been extensively studied in animal models, but are not yet fully understood. In order to identify genes influencing variation in plasma cholesterol and triglyceride levels, we previously performed a series of quantitative trait loci (QTL) analyses on plasma cholesterol and triglyceride levels in various F 2 intercrosses between mouse strains [13] [14] [15] . In one such cross, KK/Ta (hereafter referred to as KK)  RR/Sgn (hereafter referred to as RR) F 2 mice, we identified significant cholesterol QTL on the proximal part of chromosome 9 and significant triglyceride QTL on the midpart of chromosome 8, but we did not identify any other suggestive loci [15] . In the present study, I newly added data on fasting plasma glucose and body weight at 160 days after birth to previous ones and re-analyzed them with refined statistical protocols. These traits were included in the analysis in order to accomplish more comprehensive evaluation of metabolic abnormalities. The major aims of this study were as follows: (1) To set a genome-wide significance threshold by permutation test; thus, whether additional loci are identified or not was tested for each trait. (2) To perform a pairwise genome scan to reveal possible gene interactions, because gene-to-gene interactions were suggested to be involved in the manifestation of metabolic traits [2] . (3) To asses all metabolic traits simultaneously as a single multivariate character by means of principal component analysis, because a group of metabolic derangements tended to occur together [2] . In man, several genome-wide linkage studies in combination with principal component analysis successfully identified responsible chromosomal regions [1, [3] [4] [5] [6] [7] 9] . KK is known to develop NIDDM with moderate obesity. RR is not diabetes-prone, but has elevated plasma lipid levels [15] and is moderately obese; therefore, it will be appropriate to study genetic aspects of overall metabolic derangements in this F 2 set. Identification of novel loci will be some help toward further understanding of complex metabolic traits.
As described in the previous paper [15] , a total of 145 F 2 female mice were analyzed. They had free access to food [CE-2 (342.2 kcal/100 g, containing 4.4% crude fat), Clea Japan, Tokyo] and water.
Body weight was determined at 160 days after birth. Plasma blood glucose, total-cholesterol, and triglyceride levels were determined at the age of 170 days after 24-hr fasting [15] . Histograms showing distributions of body weight and plasma glucose levels in F 2 mice are shown in Fig. 1 .
The vector of the above-mentioned phenotypic measurements of four traits for each individual was handled as a single multivariate character. Therefore, the phenotypic data were analyzed by principal component analysis with SPSS for Windows (release 7.5.1-J, SPSS Inc., Chicago, IL, U.S.A.). Table 1 gives the eigenvalue and its contribution with respect to the principal component (hereafter referred to as PC) in F 2 mice. Two PCs, in which the eigenvalue was more than 1.0, were successfully extracted. They accounted for about 64% of the variation in metabolic-trait information. In the case of PC1, all coefficients for the variables were positive (Table 2) , thus suggesting that PC1 was a factor concerned with the overall severity of metabolic abnormali-ties about body weight, fasting glucose, and plasma lipids.
First, a genome-wide scan was performed for single QTL by use of Map Manager QTX b20 [12] . Prior to QTL analysis, all trait values were log-transformed to make sure of a normal distribution. The threshold likelihood ratio statistics (LRS) for suggestive (P<0.63), significant (P<0.05), and highly significant (P<0.001) linkages at the genome-wide 5% level were determined by performance of 1,000 permutations for each trait. The LRS was converted to a logarithm of odds (LOD) score by dividing of the LRS by 4.605. Once a significant QTL was identified, the 95% confidence interval (CI) was defined by 1.5 LOD fall.
The permutation-derived threshold LOD scores for suggestive and significant linkages were 1.8 and 3.1-3.3, respectively. In total, 12 single QTL were identified (Table 3 ). In particular, for PC1, one suggestive QTL was identified on chromosome 11, and one significant QTL was identified on chromosome 12 (Fig. 2) . I assigned the locus name Pc1q1 (principal component 1 QTL No. 1) to the latter locus. The 95% CI for Pc1q1 overlapped with those for two suggestive QTL for fasting glucose and total-cholesterol, and the RR allele was always associated with an increase in trait values at these loci, thus suggesting that they are allelic. It is important to note that Pc1q1 was not significant QTL for any single traits when the traits were analyzed separately. Therefore, I considered that Pc1q1 was suggested to indicate the significance of overall metabolic abnormalities. Because of a large 95% CI for Pc1q1 on chromosome 12 ( Fig. 2) , it was difficult to look for a plausible candidate gene. Nevertheless, the apolipoprotein B (Apob) gene locus could be regarded as one of the candidate loci. Apob-deficient mice were reported to have significantly lower body weight and significantly decreased total-cholesterol compared to wild-type control mice, but triglyceride levels did not differ significantly between mutant and control mice when they were fed on a chow diet [8] . Indeed, Pc1q1 had no significant effect on triglyceride levels. After single QTL scans, the potential interaction between marker loci was evaluated pairwise. For this analysis, the following two-stage test was used. First, the threshold for significance at the genome-wide 5% level was determined by performance of 1,000 permutations on the interaction model of Map Manager QTX b20, and then the significance of the total effect of the two loci was tested. Second, when pairs of loci had an LOD score exceeding the threshold, the significance of the pairwise interaction was evaluated. According to the Map Manager QTX manual, the interaction effect itself must have a P value less than 0.01. In this study, I also employed a stringent criterion, that only the pair of loci with interaction LOD scores of 3 or greater was considered to be a statistically significant interaction [11] .
The permutation-derived threshold total LOD scores for association were 7.7-8.3. One significant interaction was identified for total-cholesterol between D9Mit229 and D15Mit190 (Fig. 3) . The total LOD score association was 9.6, and the interaction LOD score was 3.6. I assigned gene symbol Cq7 (cholesterol QTL No. 7) to the locus on chromosome 15. Mice homozygous for the KK allele at D9Mit229 and heterozygous at D15Mit190 tended to have the highest cholesterol levels. There is a cluster of apolipoprotein L genes in the neighboring region of Cq7 on chromosome 15, but I have no evidence to support their candidacy. It is important to note that Cq7 was by no means identified by a single QTL scan. Taken together, these complex genetic bases could not be disclosed as long as separate a) An estimate of the size of a 95% confidence interval (CI) for a QTL, *: distal end of CI could not be defined, na: not applicable, nd: not determined because adjacent marker was distally situated. b) The amount of the total trait variance which would be explained by a QTL at this locus, in percent. c) Allele which is associated with higher trait values. d) Locus name was assigned only to significant QTLs, and * means that this locus was identified only as an interacting QTL. e) Description about overlapping QTLs for relevant trait was kept to a minimum. Fig. 3 . Identification of interacting QTL for total-cholesterol. Significant interaction was identified between D9Mit229 (Cq5) and D15Mit190 (Cq7). Error bars indicate SE.
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